These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32392184)

  • 1. Clinical trials for COVID-19 should include sex as a variable.
    Bischof E; Wolfe J; Klein SL
    J Clin Invest; 2020 Jul; 130(7):3350-3352. PubMed ID: 32392184
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving Clinical Trial Enrollment - In the Covid-19 Era and Beyond.
    North CM; Dougan ML; Sacks CA
    N Engl J Med; 2020 Oct; 383(15):1406-1408. PubMed ID: 32668133
    [No Abstract]   [Full Text] [Related]  

  • 3. Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fog.
    Di Pasquale G; Maggioni AP; Gervasoni C; Andreotti F
    J Cardiovasc Med (Hagerstown); 2020 Nov; 21(11):841-844. PubMed ID: 32858645
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on clinical trials with drugs.
    Hasford J
    Expert Opin Drug Saf; 2020 Nov; 19(11):1373-1375. PubMed ID: 32970481
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and readjusting clinical trials.
    van Dorn A
    Lancet; 2020 Aug; 396(10250):523-524. PubMed ID: 32828180
    [No Abstract]   [Full Text] [Related]  

  • 6. Return to the lab: scientists face shiftwork, masks and distancing as coronavirus lockdowns ease.
    Subbaraman N
    Nature; 2020 Jun; 582(7810):15-16. PubMed ID: 32488164
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of COVID-19 on oncology clinical trials.
    Upadhaya S; Yu JX; Oliva C; Hooton M; Hodge J; Hubbard-Lucey VM
    Nat Rev Drug Discov; 2020 Jun; 19(6):376-377. PubMed ID: 32424343
    [No Abstract]   [Full Text] [Related]  

  • 8. Completion of clinical trials in light of COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Dec; 8(12):1178-1180. PubMed ID: 33010809
    [No Abstract]   [Full Text] [Related]  

  • 9. Scientists relieved as coronavirus vaccine trial restarts - but question lack of transparency.
    Cyranoski D; Mallapaty S
    Nature; 2020 Sep; 585(7825):331-332. PubMed ID: 32929259
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety fears over drug hyped to treat the coronavirus spark global confusion.
    Ledford H
    Nature; 2020 Jun; 582(7810):18-19. PubMed ID: 32488162
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodological challenges in studying the COVID-19 pandemic crisis.
    Knottnerus JA; Tugwell P
    J Clin Epidemiol; 2020 May; 121():A5-A7. PubMed ID: 32336471
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of the lack of a unified research project framework: an investigation into the registration of clinical trials of COVID-19.
    Wang B; Lai J; Yan X; Jin F; Yao C
    Curr Med Res Opin; 2020 Jul; 36(7):1131-1135. PubMed ID: 32427000
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Ethics and Research.
    Meagher KM; Cummins NW; Bharucha AE; Badley AD; Chlan LL; Wright RS
    Mayo Clin Proc; 2020 Jun; 95(6):1119-1123. PubMed ID: 32402511
    [No Abstract]   [Full Text] [Related]  

  • 14. A Call for Pediatric COVID-19 Clinical Trials.
    Campbell JI; Ocwieja KE; Nakamura MM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32398330
    [No Abstract]   [Full Text] [Related]  

  • 15. Latin American scientific research prorities for COVID-19 prevention and control.
    Cucunubá ZM
    Biomedica; 2020 Oct; 40(Supl. 2):9-13. PubMed ID: 33152182
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials during COVID-19.
    Singh AG; Chaturvedi P
    Head Neck; 2020 Jul; 42(7):1516-1518. PubMed ID: 32348582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 18. Public Health Crises and the Human Subjects of Biomedical Research: A Focus on COVID-19.
    Sher T; Wright RS
    Mayo Clin Proc; 2020 Jun; 95(6):1130-1131. PubMed ID: 32376104
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Trial End Points in Severe COVID-19.
    Desai A; Kulkarni A; Rajkumar SV; Gyawali B
    Mayo Clin Proc; 2020 Aug; 95(8):1578-1580. PubMed ID: 32753131
    [No Abstract]   [Full Text] [Related]  

  • 20. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
    Anker SD; Butler J; Khan MS; Abraham WT; Bauersachs J; Bocchi E; Bozkurt B; Braunwald E; Chopra VK; Cleland JG; Ezekowitz J; Filippatos G; Friede T; Hernandez AF; Lam CSP; Lindenfeld J; McMurray JJV; Mehra M; Metra M; Packer M; Pieske B; Pocock SJ; Ponikowski P; Rosano GMC; Teerlink JR; Tsutsui H; Van Veldhuisen DJ; Verma S; Voors AA; Wittes J; Zannad F; Zhang J; Seferovic P; Coats AJS
    Eur Heart J; 2020 Jun; 41(22):2109-2117. PubMed ID: 32498081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.